U.S. authorizes Roche and Siemens at-home COVID-19 test

U.S. authorizes German firm Siemens Healthineers' at-home COVID-19 test The U.S. drug regulator has granted emergency use authorization to German health technology company Siemens Healthineers' at-home COVID-19 tests, a move that will boost availability of tests pressured by rising infection cases. Reuters Reuters

Dec 29 (Reuters) -  ...

The test, which is expected to be available starting January, can be used for self-testing in people as young as 14 or adult-collected samples from individuals aged 2 to 13 years, Siemens said on Wednesday.

The authorization was granted under Biden administration's accelerated review program that aims to bring tens of millions of new tests per month to the country, the Department of Health and Human Services (HHS) said. ...

ALSO SEE: Two New Over-the-Counter At-Home COVID-19 Tests Brought to U.S. Market Quickly by Biden-Harris Administration--HHS press release